Terms: = Liver cancer AND RUNX1T1, ENSG00000079102, 862 AND Treatment
49 results:
1. Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma.
Kim JI; Lee J; Choi GH; Lee MW; Park DA; Yoo JJ
Dig Dis Sci; 2024 Mar; 69(3):1055-1067. PubMed ID: 38300416
[TBL] [Abstract] [Full Text] [Related]
2. The long-term efficacy and safety of apatinib are inferior to sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis.
Li D; Zhang C; Yang K; Ma Z; Ma L; Cheng C; Xu L; Wan S
Medicine (Baltimore); 2024 Jan; 103(3):e36865. PubMed ID: 38241568
[TBL] [Abstract] [Full Text] [Related]
3. Complication Rates and Risk of Recurrence After Percutaneous Radiofrequency Ablation and Microwave Ablation for the treatment of liver Tumors: a Meta-analysis.
Alhasan AS; Daqqaq TS; Alhasan MS; Ghunaim HA; Aboualkheir M
Acad Radiol; 2024 Apr; 31(4):1288-1301. PubMed ID: 38087720
[TBL] [Abstract] [Full Text] [Related]
4. Response Evaluation Using Contrast-Enhanced Ultrasound for Unresectable Advanced Hepatocellular Carcinoma Treated With Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy.
Zhao CK; Guan X; Pu YY; Zhou BY; Wang LF; Sun YK; Yin HH; Xia HS; Wang X; Han H; Xu HX
Ultrasound Med Biol; 2024 Jan; 50(1):142-149. PubMed ID: 37852872
[TBL] [Abstract] [Full Text] [Related]
5. Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis.
Cao J; Wang Z; Zhu M; Huang Y; Jin Z; Xiong Z
Lipids Health Dis; 2023 Jul; 22(1):110. PubMed ID: 37525197
[TBL] [Abstract] [Full Text] [Related]
6. A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients.
Wu S; Lv M; Ma F; Feilong Z; Fang G; Zhang J
Eur J Clin Pharmacol; 2023 Sep; 79(9):1195-1204. PubMed ID: 37392366
[TBL] [Abstract] [Full Text] [Related]
7. Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy.
Oosterom N; Gooskens SLM; Renfro LA; Perlman EJ; van den Heuvel-Eibrink MM; Hamilton TE; Green DM; Grundy PE; Daw NC; Geller JI; Dome JS; Fernandez CV; Mullen EA
J Clin Oncol; 2023 Sep; 41(26):4247-4256. PubMed ID: 37343199
[TBL] [Abstract] [Full Text] [Related]
8. [The expression and function of PD-L1 in CD133(+) human liver cancer stem-like cells].
Bai YD; Shi ML; Li SQ; Wang XL; Peng JJ; Zhou DJ; Sun FF; Li H; Wang C; Du M; Zhang T; Li D
Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):117-128. PubMed ID: 36781232
[No Abstract] [Full Text] [Related]
9. The effect of long-acting somatostatin analogues on the uptake of [
Veerman CHAM; Siebinga H; de Vries-Huizing DMV; Tesselaar MET; Hendrikx JJMA; Stokkel MPM; Aalbersberg EA
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1434-1441. PubMed ID: 36598536
[TBL] [Abstract] [Full Text] [Related]
10. Nomogram Estimating Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma From Preoperative Gadoxetate Disodium-Enhanced MRI.
Chen FM; Du M; Qi X; Bian L; Wu D; Zhang SL; Wang J; Zhou Y; Zhu X
J Magn Reson Imaging; 2023 Jun; 57(6):1893-1905. PubMed ID: 36259347
[TBL] [Abstract] [Full Text] [Related]
11. Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B.
Kaneko S; Kurosaki M; Mashiba T; Marusawa H; Kondo M; Kojima Y; Uchida Y; Fujii H; Akahane T; Yagisawa H; Kusakabe A; Kobashi H; Abe T; Yoshida H; Ogawa C; Furuta K; Tamaki N; Tsuji K; Matsushita T; Izumi N;
J Med Virol; 2023 Jan; 95(1):e28210. PubMed ID: 36222204
[TBL] [Abstract] [Full Text] [Related]
12. A comparison of the simultaneous, liver-first, and colorectal-first strategies for surgical treatment of synchronous colorectal liver metastases at two major liver-surgery institutions in Sweden.
Frühling P; Strömberg C; Isaksson B; Urdzik J
HPB (Oxford); 2023 Jan; 25(1):26-36. PubMed ID: 36167765
[TBL] [Abstract] [Full Text] [Related]
13. Expanding Sorafenib treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic liver cancer Stage C Patients: A National Study.
Chen CT; Hsu CH; Cheng AL; Shao YY
Anticancer Res; 2022 Sep; 42(9):4461-4470. PubMed ID: 36039431
[TBL] [Abstract] [Full Text] [Related]
14. Construction and Validation of Prediction Model of Severe Abdominal Pain Post-Transarterial Chemoembolization in Patients with HBV-Associated Primary liver cancer.
Yang Y; Chen S; Yan Z; Jiao Y; Yan X; Li Y
Comput Math Methods Med; 2022; 2022():5203166. PubMed ID: 35941895
[TBL] [Abstract] [Full Text] [Related]
15. Using machine learning for mortality prediction and risk stratification in atezolizumab-treated cancer patients: Integrative analysis of eight clinical trials.
Wu Y; Zhu W; Wang J; Liu L; Zhang W; Wang Y; Shi J; Xia J; Gu Y; Qian Q; Hong Y
Cancer Med; 2023 Feb; 12(3):3744-3757. PubMed ID: 35871390
[TBL] [Abstract] [Full Text] [Related]
16. No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis B.
Chang JW; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
J Viral Hepat; 2021 Nov; 28(11):1545-1553. PubMed ID: 34382730
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and safety of selective internal radiation therapy with yttrium-90 for the treatment of unresectable hepatocellular carcinoma.
Van Thai N; Thinh NT; Ky TD; Bang MH; Giang DT; Ha LN; Son MH; Tien DD; Lee HW
BMC Gastroenterol; 2021 May; 21(1):216. PubMed ID: 33980171
[TBL] [Abstract] [Full Text] [Related]
18. Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.
Toy M; Hutton D; Harris AM; Nelson N; Salomon JA; So S
Clin Infect Dis; 2022 Jan; 74(2):210-217. PubMed ID: 33956937
[TBL] [Abstract] [Full Text] [Related]
19. Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
Jiang H; Song B; Qin Y; Chen J; Xiao D; Ha HI; Liu X; Oloruntoba-Sanders O; Erkanli A; Muir AJ; Bashir MR
Eur Radiol; 2021 Jun; 31(6):3638-3648. PubMed ID: 33245494
[TBL] [Abstract] [Full Text] [Related]
20. Multicenter Cohort Study to Assess the Association between Changes on Imaging and Outcome after Regorafenib treatment (KSCC1603).
Oki E; Kawahira M; Kusumoto T; Yuki S; Hatanaka K; Kobayashi Y; Nishie A; Kawanami S; Makiyama A; Saeki H; Sakamoto S; Komatsu Y; Shimokawa M; Mori M; Esaki T
Oncology; 2020; 98(10):719-726. PubMed ID: 32640458
[TBL] [Abstract] [Full Text] [Related]
[Next]
